Detalhe da pesquisa
1.
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.
J Virol
; 95(11)2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658341
2.
Predictors of Nonseroconversion after SARS-CoV-2 Infection.
Emerg Infect Dis
; 27(9): 2454-2458, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193339
3.
Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
J Virol
; 94(8)2020 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969435
4.
Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.
Proc Natl Acad Sci U S A
; 113(24): E3413-22, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27247400
5.
Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
J Virol
; 89(24): 12388-400, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423953
6.
The major cellular sterol regulatory pathway is required for Andes virus infection.
PLoS Pathog
; 10(2): e1003911, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24516383
7.
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.
J Virol
; 87(5): 2401-11, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269796
8.
Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.
J Virol
; 85(1): 470-80, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20962094
9.
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.
Science
; 371(6525)2021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214287
10.
A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
J Virol
; 83(10): 4861-70, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264785
11.
Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4.
J Virol
; 83(21): 11005-15, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692476
12.
An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
J Virol
; 82(13): 6447-57, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18434410
13.
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
PLoS Pathog
; 3(8): e117, 2007 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-17722977
14.
Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140.
AIDS Res Hum Retroviruses
; 24(2): 301-14, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18284327
15.
Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment.
AIDS Res Hum Retroviruses
; 32(7): 705-17, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847431
16.
Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
Vaccine
; 33(39): 5140-7, 2015 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26277072
17.
Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.
Virology
; 402(1): 135-48, 2010 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20381825
18.
Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.
J Virol
; 81(12): 6548-62, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409160
19.
Functional impact of HIV coreceptor-binding site mutations.
Virology
; 351(1): 226-36, 2006 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16631222
20.
Enfuvirtide resistance mutations: impact on human immunodeficiency virus envelope function, entry inhibitor sensitivity, and virus neutralization.
J Virol
; 79(8): 4991-9, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15795284